ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

ANIX Anixa Biosciences Inc

2,94
-0,03 (-1,01%)
04 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Anixa Biosciences Inc ANIX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,03 -1,01% 2,94 06:00:04
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,01 2,85 3,06 2,94 2,97
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202413:45PRNUSAnixa Biosciences to Participate in the Sidoti Micro-Cap..
18.4.202414:20PRNUSAnixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay..
14.3.202413:45PRNUSAnixa Biosciences 2024 Annual Meeting of Stockholders to..
11.3.202413:00PRNUSAnixa Biosciences Announces Presentation at 24th Annual..
12.2.202413:30PRNUSAnixa Biosciences Initiates Dosing in Second Cohort of..
08.2.202422:15EDGAR2Form DEF 14A - Other definitive proxy statements
29.1.202414:50PRNUSAnixa Biosciences Announces Participation in 2024..
23.1.202413:55PRNUSAnixa Biosciences Announces Japanese Patent on Ovarian..
17.1.202401:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202401:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202401:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.1.202423:29EDGAR2Form SC 13D/A - General statement of acquisition of..
16.1.202422:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
16.1.202422:30EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
10.1.202415:00PRNUSAnixa Biosciences to Present at Sidoti Micro-Cap Virtual..
14.12.202313:15PRNUSAnixa Biosciences to Present at Biotech Showcase 2024
07.12.202312:01EDGAR2Form 8-K - Current report
07.12.202300:00PRNUSAnixa Biosciences and Cleveland Clinic Present Positive New..
06.12.202322:05PRNUSAnixa Biosciences to Host Conference Call This Evening to..
27.11.202314:30PRNUSAnixa Biosciences Announces European Patent on Ovarian..
02.11.202315:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.10.202313:30PRNUSAnixa Biosciences to Present at the Ovarian Cancer Research..
23.10.202314:30PRNUSAnixa Biosciences Appoints Accomplished Medical Oncologist..
13.10.202314:30PRNUSAnixa Biosciences Completes Treatment of First Patient..
11.10.202316:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202314:30PRNUSAnixa Biosciences Announces Issuance of Additional U.S...
19.9.202314:30PRNUSAnixa Biosciences Establishes Cancer Business Advisory Board
06.9.202322:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31.8.202314:30PRNUSAnixa Biosciences to Participate in September Investor..
28.8.202314:30PRNUSAnixa Biosciences Announces Treatment of Third Patient in..
14.8.202314:30PRNUSAnixa Biosciences Announces Invited Presentation on Ovarian..
07.8.202314:30PRNUSAnixa Biosciences Announces Opening of Enrollment for..
01.8.202300:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.8.202300:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.7.202314:30PRNUSAnixa Biosciences Announces Notice of Allowance of..
21.7.202316:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.7.202314:30PRNUSAnixa Biosciences Announces Issuance of Canadian Patent for..
22.5.202314:30PRNUSAnixa Biosciences Announces Treatment of Second Patient in..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock